Hints and tips:
...Boston Scientific and Edwards Lifesciences, both of which have large cardiovascular businesses, command an average multiple of around 22....
...“If anything, I’m more excited,” said Kaptein of Integra Partners....
...Many Indian entrepreneurs have been slowing organic expansion at home and boosting foreign buyouts, such as UPL Corp’s takeover of US-based Arysta LifeScience....
...Medical technology group Integra LifeSciences has announced plans to buy Johnson & Johnson’s Codman neurosurgery business for just over $1bn in cash....
...Glencore announced last week it would restart production at the Integra underground mine in New South Wales, Australia, saying it expected to mine 1.3m tonnes of material....
...The fund house, which oversees $2.5bn in assets, turned to the Cayman court system after the management of Integra, the Russian oilfield services company, proposed a buyout in March 2014....
...The Aim-listed stock fell 13 per cent on Monday after the company ended an agreement with Arysta LifeScience to develop and sell treatments in the US combining PHC’s protein technology for improving crop...
...Edwards Lifesciences Corp rose 1.87 per cent to close at $145.12. Genworth Financial and Western Digital Corp shed last week’s gains, falling 3.36 per cent to $7.48 and 1.30 per cent to $79.82....
...Backed by Bill Ackman’s Pershing Square hedge fund, Platform Speciality has in the past year added to its portfolio Arysta LifeSciences for $5.4bn, and OM Group for $365m....
...Platform Specialty Products, the company backed by activist investor Bill Ackman, has agreed to buy Arysta LifeScience in a deal valuing the Irish agriculture chemical maker at $3.51bn, including debt....
...device maker received an unfavourable ruling from a federal court in Delaware banning it from selling its aortic heart valve replacement system, which was earlier found to infringe a patent by rival Edwards Lifesciences...
...Stuart’s early career began at Oracle and he has worked on major data and information initiatives for companies including United Healthcare Group, Edwards Lifesciences and most recently Spectrum Pharmaceuticals...
...Sura, which snapped up ING’s Latin American pensions assets in 2011 for $3.85bn and already controls another Peruvian pension fund, Integra, named Profuturo AFP, controlled by Scotiabank, as its strategic...
...We also note the company’s significant leverage, and the transitional period following the addition of Integra and Geotech assets may limit the company’s development in 2013....
...capacities including, variously, chairman, chief executive, committee chair, senior adviser and board member of pharmaceutical, life sciences and investment companies such as GlaxoSmithKline, Allergan Inc...
...Those are, AFP Horizonte mostly owned mainly by BBVA Continental; AFP Integra owned by Colombia’s Grupo Sura; Prima AFP run by Peru’s Credicorp, and AFP Profuturo controlled by Scotiabank....
...Edwards Lifesciences tumbled 21.2 per cent to $84.6, making it the worst-hit stock on the S&P 500, after the cardiovascular equipment maker warned that third-quarter revenues would be lower than expected...
...Silver Lake, which announced plans last month to buy rival gold producer Integra Mining, climbed 9.1 per cent to A$3.24, while Integra rose 6.4 per cent to A$0.50....
...Edwards Lifesciences tumbled 14 per cent to $92.30 in after-market trading as the maker of cardiovascular equipment said sales for the third quarter would fall short of market expectations....
...Permira’s last deal, the Y100bn acquisition of Tokyo-based Arysta LifeScience in October 2007, was another secondary buyout, from a Hong Kong-based investment group....
...Edwards Lifesciences climbed 5.1 per cent to $67.85, on the back of upgrades from several analysts. A Morgan Keegan noted pointed to the group’s strong product pipeline and prospects in China....
...Siemens has 4 per cent, but the most interesting investor is Edwards Lifesciences, world market leader in heart valves, which is quoted on the New York Stock Exchange with a market capitalisation of $8bn...
...Edwards LifeSciences tumbled after the administrator of the government’s Medicare and Medicaid programmes dealt a blow to hopes of a rapid roll-out for its new cardiovascular device....
...But for every one in five workers who supposedly quit because of stress (Integra Survey, 2000) or the 25 per cent who feel “often or very burnt out” (NIOSH, 1999) there is a contrarian spin....
...Among the pension funds and insurance groups Grupo Sura has bought stakes are Peru’s Integra and ING Fondos....
International Edition